Kiromic BioPharma Incorporated is developing multi-indication allogeneic T cell therapies that exploit the natural potency of the Gamma Delta T cell to target solid tumors. Kiromic BioPharma was founded in 2006 and is headquartered in Houston, TX.
Zen Score
–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how KRBP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KRBP ($0.27) is overvalued by 3.59% relative to our estimate of its Fair Value price of $0.26 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
KRBP ($0.27) is not significantly undervalued (3.59%) relative to our estimate of its Fair Value price of $0.26 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
NASDAQ: KRBP) Kiromic Biopharma trades on the NASDAQ under the ticker symbol KRBP. Kiromic Biopharma stock quotes can also be displayed as NASDAQ: KRBP.
What is the 52 week high and low for Kiromic Biopharma (NASDAQ: KRBP)?
(NASDAQ: KRBP) Kiromic Biopharma's 52-week high was $1.04, and its 52-week low was $0.15. It is currently -74.52% from its 52-week high and 76.67% from its 52-week low.
How much is Kiromic Biopharma stock worth today?
(NASDAQ: KRBP) Kiromic Biopharma currently has 18,246,718 outstanding shares. With Kiromic Biopharma stock trading at $0.27 per share, the total value of Kiromic Biopharma stock (market capitalization) is $4.84M.
Kiromic Biopharma stock was originally listed at a price of $11.50 in Oct 16, 2020. If you had invested in Kiromic Biopharma stock at $11.50, your return over the last 2 years would have been -97.7%, for an annualized return of -84.82% (not including any dividends or dividend reinvestments).
How much is Kiromic Biopharma's stock price per share?
(NASDAQ: KRBP) Kiromic Biopharma stock price per share is $0.27 today (as of Feb 6, 2023).
What is Kiromic Biopharma's Market Cap?
(NASDAQ: KRBP) Kiromic Biopharma's market cap is $4.84M, as of Feb 8, 2023.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Kiromic Biopharma's market cap is calculated by multiplying KRBP's current stock price of $0.27 by KRBP's total outstanding shares of 18,246,718.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.